IRIS Accounts Production v23.1.0.753 08992063 director 1.5.22 30.4.23 30.4.23 consultancy in healthcare. false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure089920632022-04-30089920632023-04-30089920632022-05-012023-04-30089920632021-04-30089920632021-05-012022-04-30089920632022-04-3008992063ns15:EnglandWales2022-05-012023-04-3008992063ns14:PoundSterling2022-05-012023-04-3008992063ns10:Director12022-05-012023-04-3008992063ns10:PrivateLimitedCompanyLtd2022-05-012023-04-3008992063ns10:SmallEntities2022-05-012023-04-3008992063ns10:AuditExemptWithAccountantsReport2022-05-012023-04-3008992063ns10:SmallCompaniesRegimeForDirectorsReport2022-05-012023-04-3008992063ns10:SmallCompaniesRegimeForAccounts2022-05-012023-04-3008992063ns10:FullAccounts2022-05-012023-04-3008992063ns10:CompanySecretary12022-05-012023-04-3008992063ns10:RegisteredOffice2022-05-012023-04-3008992063ns5:CurrentFinancialInstruments2023-04-3008992063ns5:CurrentFinancialInstruments2022-04-3008992063ns5:ShareCapital2023-04-3008992063ns5:ShareCapital2022-04-3008992063ns5:RetainedEarningsAccumulatedLosses2023-04-3008992063ns5:RetainedEarningsAccumulatedLosses2022-04-30
REGISTERED NUMBER: 08992063 (England and Wales)















Report of the Director and

Unaudited Financial Statements for the Year Ended 30 April 2023

for

The Soul Nurse Limited

The Soul Nurse Limited (Registered number: 08992063)






Contents of the Financial Statements
for the Year Ended 30 April 2023




Page

Company Information 1

Report of the Director 2

Income Statement 3

Balance Sheet 4

Notes to the Financial Statements 5


The Soul Nurse Limited

Company Information
for the Year Ended 30 April 2023







DIRECTOR: Miss J La Bouche Grandison





SECRETARY:





REGISTERED OFFICE: 341 Garratt Lane
Earlsfield
Wandsworth
London
SW18 4DX





REGISTERED NUMBER: 08992063 (England and Wales)





ACCOUNTANTS: MSS Accountancy Services Ltd
341 Garratt Lane
Wandsworth
London
SW18 4DX

The Soul Nurse Limited (Registered number: 08992063)

Report of the Director
for the Year Ended 30 April 2023

The director presents her report with the financial statements of the company for the year ended 30 April 2023.

DIRECTOR
Miss J La Bouche Grandison held office during the whole of the period from 1 May 2022 to the date of this report.

This report has been prepared in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

ON BEHALF OF THE BOARD:





Miss J La Bouche Grandison - Director


31 January 2024

The Soul Nurse Limited (Registered number: 08992063)

Income Statement
for the Year Ended 30 April 2023

30.4.23 30.4.22
£    £   

TURNOVER - 330

Administrative expenses 120 2,359
OPERATING LOSS and
LOSS BEFORE TAXATION (120 ) (2,029 )

Tax on loss - -
LOSS FOR THE FINANCIAL YEAR (120 ) (2,029 )

The Soul Nurse Limited (Registered number: 08992063)

Balance Sheet
30 April 2023

30.4.23 30.4.22
Notes £    £   

CREDITORS
Amounts falling due within one year 4 19,633 19,513
NET CURRENT LIABILITIES (19,633 ) (19,513 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

(19,633

)

(19,513

)

CAPITAL AND RESERVES
Called up share capital 1 1
Retained earnings (19,634 ) (19,514 )
SHAREHOLDERS' FUNDS (19,633 ) (19,513 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 April 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 April 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 31 January 2024 and were signed by:





Miss J La Bouche Grandison - Director


The Soul Nurse Limited (Registered number: 08992063)

Notes to the Financial Statements
for the Year Ended 30 April 2023

1. STATUTORY INFORMATION

The Soul Nurse Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2022 - 1 ) .

4. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.4.23 30.4.22
£    £   
Trade creditors 120 120
Other creditors 19,513 19,393
19,633 19,513